Form 4: VirnetX Director Thomas O'Brien Acquires 7,500 Restricted Shares
Insider Transaction Report
VirnetX Holding Corp Director Thomas M. O'Brien has acquired 7,500 shares of common stock as restricted stock, increasing his direct beneficial ownership to 27,332 shares.
Summary
- Thomas M. O'Brien, a Director of VirnetX Holding Corp (VHC), acquired 7,500 shares of common stock.
- The transaction occurred on June 12, 2025.
- These shares were acquired at a price of $0, indicating they are restricted stock granted by the company.
- Following this acquisition, Mr. O'Brien directly beneficially owns a total of 27,332 shares of VirnetX common stock.
- The 7,500 restricted shares will vest on the earlier of the one-year anniversary of the grant date (June 12, 2026) or the day prior to the Company's 2026 annual meeting of stockholders, provided Mr. O'Brien maintains his status as a Service Provider.
- Vesting will accelerate immediately prior to the consummation of a Change in Control.
Sentiment
Score: 7
Explanation: The acquisition of restricted stock by a director is generally a positive signal, indicating alignment of interests and confidence in the company's future. While not a cash purchase, it still represents a commitment to the company's long-term success.
Positives
- A director acquiring shares, even restricted stock, can signal confidence in the company's future prospects.
- The grant of restricted stock aligns the director's interests with those of shareholders, promoting long-term value creation.
Risks
- The vesting of the restricted stock is contingent on the director's continuous status as a Service Provider, meaning if he ceases to be a service provider before the vesting date, the shares may be forfeited.
- The value of the restricted stock is tied to the future performance of VirnetX's common stock, exposing the director to market risk.
Future Outlook
The document indicates future vesting events for the restricted stock, contingent on the director's continued service and potentially accelerated by a Change in Control, aligning future incentives.
Management Comments
- The filing is a standard regulatory disclosure and does not contain direct quotes or paraphrased statements from management beyond the transaction details.
Industry Context
This Form 4 filing is a routine disclosure of an insider transaction, common across all industries. It reflects standard corporate governance practices where directors receive equity compensation to align their interests with shareholders.
Comparison to Industry Standards
- The grant of restricted stock to a director at a $0 price is a common form of equity compensation, aligning with typical industry practices for executive and director incentives.
- The vesting schedule (one-year anniversary or prior to the next annual meeting) is a standard approach to encourage retention and long-term commitment, comparable to similar plans at technology companies.
- The acceleration of vesting upon a Change in Control is also a standard provision in many equity incentive plans, designed to protect executive and director interests during corporate transitions.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Compensation | Grant of 7,500 restricted shares to Director Thomas M. O'Brien under the Company's Amended and Restated 2013 Equity Incentive Plan. | 06/12/2025 | Aligns director's interests with shareholders and serves as a retention incentive. |
Related Party Transactions
- The acquisition of 7,500 restricted shares by Director Thomas M. O'Brien is a related party transaction, as it involves an equity grant from the company to an insider.
Stakeholder Impact
- Shareholders: May view the director's acquisition of shares as a positive indicator of insider confidence, potentially leading to increased investor trust.
- Employees: The equity incentive plan, under which these shares were granted, is a standard mechanism for aligning employee and director interests with company performance.
Next Steps
- Vesting of 7,500 restricted shares on the earlier of June 12, 2026, or the day prior to the Company's 2026 annual meeting of stockholders, subject to continuous service.
- Potential accelerated vesting upon a Change in Control.
Key Dates
| Date | Description |
|---|---|
| 06/12/2025 | Date of earliest transaction: Acquisition of 7,500 restricted shares by Director Thomas M. O'Brien. |
| 06/16/2025 | Signature date of the Form 4 filing. |
| 06/12/2026 | One-year anniversary of the grant date, a potential vesting date for the restricted shares. |
| 2026 | Year of the Company's annual meeting of stockholders, the day prior to which is another potential vesting date for the restricted shares. |
Keywords
VirnetX Holding Corp, VHC, SEC Form 4, insider transaction, restricted stock, stock grant, director compensation, beneficial ownership, equity incentive plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.